Neil E. Stahl - 16 Dec 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research and Development
Signature
/s/ Neil E. Stahl
Issuer symbol
REGN
Transactions as of
16 Dec 2024
Net transactions value
-$222,166
Form type
4
Filing time
18 Dec 2024, 16:02:59 UTC
Previous filing
10 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Tax liability $222,166 -304 -0.62% $730.81 48,829 16 Dec 2024 Direct
holding REGN Common Stock 5,849 16 Dec 2024 By 401(k) Plan
holding REGN Common Stock 4,605 16 Dec 2024 by Spouse as Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.